NEU neuren pharmaceuticals limited

Ann: Presentations and publication for Rett syndrome trials, page-4

  1. 2,804 Posts.
    lightbulb Created with Sketch. 549
    Yes the whole issue of open access to scientific research has been in the news a lot recently. For example, not so long ago Elsevier took legal action against the Sci-Hub website for providing access to what Elsevier regarded as its corporate property. Elsevier's publishing model is arguably one of the most profitable (and some would say predatory) in the world, and it will be interesting to see what will be the long term impact of sites such as Sci-Hub, which for most scientists in developing (and developed!) nations is the first port of call in looking up papers now.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
0.000(0.00%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.48 $16.77 $16.28 $3.108M 188.0K

Buyers (Bids)

No. Vol. Price($)
1 105 $16.48
 

Sellers (Offers)

Price($) Vol. No.
$16.54 885 2
View Market Depth
Last trade - 16.13pm 28/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.